Open AccessDOAJ SealDOAJCrossrefOpenAlex
MedComm
Metadata for this journal is being automatically enriched from connected scholarly data sources.
Journal information
- Publisher
- Wiley
- Subjects
- biomedicine · Cancer Immunotherapy and Biomarkers · Cancer-related molecular mechanisms research · clinical medicine · disease treatment · drug discovery · Epigenetics and DNA Methylation · Ferroptosis and cancer prognosis · Immune Cell Function and Interaction · Immune cells in cancer · Medicine · pathogenesis · R · RNA modifications and cancer · SARS-CoV-2 and COVID-19 Research
- Country
- AU
- Languages
- EN
- ISSN
- 2688-2663
- E-ISSN
- 2688-2663
- ISSN-L
- 2688-2663
- Open access
- Yes
- OA since
- 2020
- Publication years
- 1976–2026
- APC (summary)
- —
- Website
- Visit journal ↗
Journal Classification
Classification is derived from this journal’s 2024–2025 publications using the OpenAlex taxonomy.
- Classification
- Field / Subfield
- Primary Field
- Medicine
- Primary Subfield
- Oncology
- Domain
- Health Sciences
- Confidence
- Medium
- Publications classified
- 876
- Classification version
- OAJF Classification v1.1
APC records
- OPENALEX · 2026
- 3,050 EUR
- OPENALEX · 2026
- 2,550 GBP
- OPENALEX · 2026
- 3,500 USD
- DOAJ · 2026
- 3,360 EUR
- DOAJ · 2026
- 2,810 GBP
- DOAJ · 2026
- 3,850 USD
